Learn how to properly document safety alerts on medication lists to prevent deadly errors. Follow evidence-based steps from ISMP and WHO guidelines to protect patients using high-risk drugs like insulin, opioids, and anticoagulants.
Mycophenolate commonly causes nausea and diarrhea, but these side effects can be managed with dose adjustments, timing changes, probiotics, and switching formulations. Learn proven strategies to stay on this critical immunosuppressant without suffering.
Targeted and cellular therapies are transforming leukemia and lymphoma treatment, offering deeper remissions, fewer side effects, and new hope for patients who once had few options. Learn how these breakthroughs work and who benefits most.
State laws on generic drug substitution vary widely across the U.S., affecting how pharmacists switch brand-name drugs for generics. Learn how consent rules, liability protections, and narrow therapeutic index drugs create a patchwork system-and what patients and pharmacists need to know.
The FDA is cracking down on manufacturing quality failures in pharma and medical devices. Learn the top 4 issues - aseptic processing, data integrity, material control, and process validation - and why culture is now the biggest red flag.
Combining blood thinners with NSAIDs like ibuprofen or naproxen can cause life-threatening bleeding. Learn why this interaction is so dangerous, which drugs pose the highest risk, and what safer alternatives exist.
Learn how to tell the difference between food and medication allergies based on timing, symptoms, immune response, and testing. Misdiagnosis can lead to dangerous outcomes - here’s how to get it right.
Geriatric medication safety is critical as older adults face higher risks from drug interactions, polypharmacy, and inappropriate prescriptions. Learn how the Beers Criteria, deprescribing, and multidisciplinary teams are reducing harm and saving lives.
Certain medications can silently scar the lungs, causing drug-induced pulmonary fibrosis. Learn which drugs pose the highest risk, how to spot early symptoms, and what to do if you’re affected.
Serious adverse events from generic drugs are underreported due to confusing labeling and reporting systems. Learn how to correctly report reactions to the FDA, why the data gap matters, and what’s being done to fix it.